100 related articles for article (PubMed ID: 1713125)
1. Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer.
Kaneko S; Ishida T; Sugio K; Yokoyama H; Sugimachi K
Cancer Res; 1991 Aug; 51(15):4008-11. PubMed ID: 1713125
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of nucleolar organizer regions (Ag-NORs) in primary lung cancer--correlation between Ag-NORs and tumor doubling time].
Usuda K; Saito Y; Aikawa H; Sakurada A; Endo C; Takahashi S; Kanma K; Sato M; Sagawa M; Fujimura S
Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):545-50. PubMed ID: 8035075
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis.
Lipponen PK; Eskelinen MJ
Anticancer Res; 1991; 11(1):75-80. PubMed ID: 2018387
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
7. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
8. Ag-NORs related to flow cytometry, morphometry and prognosis in patients with pancreatic cancer.
Mäkinen K; Eskelinen M; Lipponen P; Nuutinen P; Marin S; Alhava E
Anticancer Res; 1993; 13(1):157-60. PubMed ID: 8476207
[TBL] [Abstract][Full Text] [Related]
9. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
10. [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer].
Raĭkhlin NT; Bukaeva IA; Smirnova EA; Gurevich LE; Delektorskaia VV; Polotskiĭ BE; Laktionov KK; Ardzinba Ms
Arkh Patol; 2008; 70(3):15-8. PubMed ID: 18727426
[TBL] [Abstract][Full Text] [Related]
11. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
12. Silver stained nucleolar organizer region proteins (Ag-NORs) as a predictor of prognosis in colonic cancer.
Ofner D; Tötsch M; Sandbichler P; Hallbrucker C; Margreiter R; Mikuz G; Schmid KW
J Pathol; 1990 Sep; 162(1):43-9. PubMed ID: 2231191
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
14. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of operated non-small-cell bronchogenic cancer: critical analysis of T.N.M].
Riquet M; Manac'h D; Le Pimpec Barthes F; Souilamas R; Paris E; Dujon A; Debesse B
Rev Pneumol Clin; 1996; 52(3):181-7. PubMed ID: 8763637
[TBL] [Abstract][Full Text] [Related]
16. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
17. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Gong M
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
[TBL] [Abstract][Full Text] [Related]
18. Results of pneumonectomy for non-small cell lung cancer: appropriateness of the new TNM staging system.
Mizushima Y; Noto H; Kusajima Y; Sugiyama S; Yamashita R; Sassa K; Kobayashi M
Oncol Rep; 1998; 5(2):437-40. PubMed ID: 9468575
[TBL] [Abstract][Full Text] [Related]
19. A better prognostic value from a modification of lung cancer staging.
Roeslin N; Chalkiadakis G; Dumont P; Witz JP
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):504-9. PubMed ID: 2821327
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
